SIPO: patent application should be filed in time

An officer of the State Intellectual Property Office (SIPO) said, enterprises shall not remember to apply for patent and protection until the products or the achievements have come out.

Patent application shall be filed in the beginning phase of R&D and have a clear target.

Director of the Material Engineering Examination Department of the SIPO Zheng Huifen introduced that although domestic patent applications of biological technology are of large amount, the grant rate of patents is lower than that of foreign ones.

Besides, in terms of applying items, most domestic ones are conceptual, but foreign ones are with high added value.

As to patent grant, domestic patent products are produced on the improvement of the existing similar products with weak innovative abilities.

As the world pays increasing attention to biological technology and competition is becoming fierce, China shall enlarge the investment in the fields with high industrialized added value, such as biological medicine, enhance enterprises’ IPR protection awareness and further promote the transformation of S&T achievements, expressed Zheng. [Chinese version is available on Xinhua]